Insights into Acute Myeloid Leukemia: Critical Analysis on its Wide Aspects
Open Access
- 31 December 2020
- journal article
- Published by Abasyn University in Abasyn Journal of Life Sciences
Abstract
Acute myeloid leukaemia (AML) is a heterogeneous, most common type of acute leukaemia that involves mutation in haematopoietic and progenitors stem cells (HPSCs) leading to uncontrolled division, self-renewal and differentiation. Though it was untreatable about a half century ago, AML is now considered to be treatable in up to 40% of adults and those who are at or under 60 years of age. For the post-induction treatment, the mutation testing and cytogenetics are still an important prognostic tool. The AML treatment remains unchanged for almost three decades, although the field is advanced with the discovery of new drugs and deep understanding of the disease biology. Still, many people are relapsing and are dying eventually from the disease. This review discusses the broader aspects of AML, reflecting some of the most important and productive areas of research on the subject and was conducted using thoroughly searching databases, including Health Research and Development Information network Plus (HERDIN Plus), google scholar and PubMed to critically analyses the recent advances, available treatments and future prospectives of AML.Keywords
This publication has 47 references indexed in Scilit:
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemiaBlood, 2011
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeThe New England Journal of Medicine, 2009
- Chronic Myelogenous Leukemia,BCR-ABL1+American Journal of Clinical Pathology, 2009
- Mutation inTET2in Myeloid CancersThe New England Journal of Medicine, 2009
- A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBlood, 2009
- Is it important to decipher the heterogeneity of “normal karyotype AML”?Best Practice & Research Clinical Haematology, 2008
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- Biology and management of relapsed acute myeloid leukaemiaBritish Journal of Haematology, 2005